NasdaqGS:DXCMMedical Equipment
DexCom (DXCM) Wins Health Canada Approval, Is The Stock Trading At A Discount?
DexCom (DXCM) is back in focus after Health Canada authorized the Dexcom G7 15 Day continuous glucose monitoring system, extending approved sensor wear to 15.5 days for adults with diabetes.
See our latest analysis for DexCom.
At a share price of $71.54, DexCom has seen a 20.6% 90 day share price return even as the 1 year total shareholder return is down 20.1%. This suggests recent momentum has improved while longer term holders still sit on losses.
If this kind of regulatory catalyst has...